MARKET

RMD

RMD

Resmed
NYSE
208.34
+2.14
+1.04%
Closed 17:41 07/25 EDT
OPEN
204.85
PREV CLOSE
206.20
HIGH
212.78
LOW
203.86
VOLUME
2.02M
TURNOVER
0
52 WEEK HIGH
229.97
52 WEEK LOW
131.19
MARKET CAP
30.61B
P/E (TTM)
32.07
1D
5D
1M
3M
1Y
5Y
1D
*ResMed Price Target Raised 1.6% to A$35.40/Share by Macquarie
Dow Jones · 2d ago
Microsoft To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday
Goldman Sachs cut the price target for SunPower Corporation (NASDAQ:SPWR) on Monday. RBC Capital raised ResMed Inc. Price target from $200 to $204. Piper Sandler increased the price targets for Microsoft Corporation and Walgreens Boots Alliance. CrowdStrike Holdings, Inc. Shares fell 13.5%.
Benzinga · 3d ago
What 6 Analyst Ratings Have To Say About ResMed
ResMed is one of the largest respiratory care device companies globally. The company has an average 12-month price target of $219.0. Six analysts have shared their evaluations of ResMed in the last three months. ResMed has a positive revenue growth rate of 7.17%. The company is developing products for the treatment of sleep apnea.
Benzinga · 3d ago
ResMed Is Maintained at Sector Perform by RBC Capital
Dow Jones · 3d ago
ResMed Price Target Raised to $204.00/Share From $200.00 by RBC Capital
Dow Jones · 3d ago
RBC Capital Maintains Sector Perform on ResMed, Raises Price Target to $204
Benzinga · 3d ago
LeMaitre Vascular: A Small Cap With Best-In-Industry Growth
Seeking Alpha · 3d ago
Weekly Report: what happened at RMD last week (0715-0719)?
Weekly Report · 4d ago
More
About RMD
ResMed Inc. is a holding company. The Company, through its subsidiaries, is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. The Company’s segments include Sleep and Respiratory Care and Software as a Service. SDB includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital software health applications, along with its devices, are designed to provide connected care to improve patient outcomes. Its portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, and cloud-based software and informatics solutions. Its comprehensive out-of-hospital software platforms support the professionals and caregivers.

Webull offers Resmed Inc stock information, including NYSE: RMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RMD stock methods without spending real money on the virtual paper trading platform.